Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Prostatic Hypertrophy, Benign
Interventions
DRUG

Vardenafil (Levitra, BAY38-9456)

One tablet vardenafil 10 mg with a glass of water the evening before ablation of prostate; the second dose (vardenafil 20 mg) with a glass of water approximately one hour before Greenlight(TM) laser ablation of prostate commenced.

DRUG

Placebo

One placebo tablet with a glass of water the evening before ablation of prostate; the second placebo dose with a glass of water approximately one hour before Greenlight(TM) laser ablation of prostate commenced.

Trial Locations (1)

69112

Heidelberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY